[FG] Pfister Marc

Bräm, D.S. et al. (2024) ‘Low‐dimensional neural ordinary differential equations accounting for inter‐individual variability implemented in Monolix and NONMEM’, CPT: Pharmacometrics & Systems Pharmacology [Preprint]. Available at: https://doi.org/10.1002/psp4.13265.

Muff, Rafael et al. (2024) ‘Serum Sodium Concentration During Arginine Vasopressin Infusion in Critically Ill Children’, Children, 11(11), p. 1359. Available at: https://doi.org/10.3390/children11111359.

Ajayi, David T. et al. (2024) ‘Pharmacometric Analysis to Describe Pharmacokinetics and Exposure‐Efficacy Response of Ivermectin in Adolescents Infected with Trichuris trichiura’, The Journal of Clinical Pharmacology [Preprint]. Available at: https://doi.org/10.1002/jcph.6158.

Golhen, K. et al. (2024) ‘Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg’, Pharmaceutics, 16(9), p. 1186. Available at: https://doi.org/10.3390/pharmaceutics16091186.

Vancauwenberghe, Laure et al. (2024) ‘Swiss COVID-19 hospital surveillance: an in-depth analysis of the factors associated with hospital readmission dynamics in community-acquired COVID-19 cases’, Swiss Medical Weekly, 154(9), p. 3773. Available at: https://doi.org/10.57187/s.3773.

Anliker‐Ort, Marion et al. (2024) ‘Pharmacokinetics‐Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study’, The Journal of Clinical Pharmacology, 64(7), pp. 810–819. Available at: https://doi.org/10.1002/jcph.2428.

Fenner, A. et al. (2024) ‘Antibiotic Exposure of Critically Ill Children at a Tertiary Care Paediatric Intensive Care Unit in Switzerland’, Children, 11(6). Available at: https://doi.org/10.3390/children11060731.

Pillay-Fuentes Lorente, Veshni et al. (2024) ‘Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d’Ivoire’, Drugs in R&amp;D, 24(2), pp. 331–340. Available at: https://doi.org/10.1007/s40268-024-00476-4.

Dao, Kim et al. (2024) ‘Novel Patient‐Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use’, The Journal of Clinical Pharmacology. 30.05.2024, 64(10), pp. 1295–1303. Available at: https://doi.org/10.1002/jcph.2462.

Bräm, D.S. et al. (2024) ‘Applying Neural ODEs to Derive a Mechanism-Based Model for Characterizing Maturation-Related Serum Creatinine Dynamics in Preterm Newborns’, Journal of Clinical Pharmacology [Preprint]. Available at: https://doi.org/10.1002/jcph.2460.

Gotta, Verena et al. (2024) ‘Pharmacometric in silico studies used to facilitate a national dose standardisation process in neonatology - application to amikacin’, Swiss Medical Weekly, 154. Available at: https://doi.org/10.57187/s.3632.

Lass, Jana et al. (2024) ‘Pharmacokinetics of oral spironolactone in infants up to 2 years of age’, European Journal of Clinical Pharmacology, 80, pp. 239–248. Available at: https://doi.org/10.1007/s00228-023-03599-w.

Ulziibat, M. et al. (2024) ‘Microbiological Spectrum of Osteoarticular Infections and Their Management in Mongolian Children’, Global Pediatric Health, 11. Available at: https://doi.org/10.1177/2333794x241298801.

Welzel, Tatjana et al. (2024) ‘Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases’, Pediatric Rheumatology, 22. Available at: https://doi.org/10.1186/s12969-023-00930-8.

Ehlers, Lisa et al. (2023) ‘Treat-to-target strategies for the management of familial Mediterranean Fever in children’, Pediatric Rheumatology, 21(1). Available at: https://doi.org/10.1186/s12969-023-00875-y.

Satirer, Özlem et al. (2023) ‘Cryopyrin-assoziierte periodische Syndrome’, Arthritis und Rheuma, 43(04), pp. 264–274. Available at: https://doi.org/10.1055/a-2114-0449.

Weber, A.N.R. et al. (2023) ‘Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3: Reply’, Rheumatology (United Kingdom), 62(5), pp. E168–E169. Available at: https://doi.org/10.1093/rheumatology/keac718.

Welzel, T., Woerner, A. and Kaiser, D. (2023) ‘Arthrite juvénile idiopathique systémique, une mise au point’, Paediatrica, 35(1). Available at: https://doi.org/10.35190/paediatrica.f.2024.1.4.

Golhen K et al. (2023) ‘Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children.’, Pharmaceutics, 15(4). Available at: https://doi.org/10.3390/pharmaceutics15041033.

Smit, C. et al. (2023) ‘Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why?’, Neonatology, 120(1), pp. 81–89. Available at: https://doi.org/10.1159/000526210.

Anliker-Ort, Marion et al. (2023) ‘Modeling time-delayed concentration-QT effects with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5a<inf>1</inf> receptor) antagonist’, Pharmacology Research and Perspectives, 11. Available at: https://doi.org/10.1002/prp2.1112.

Bachmann, Freya et al. (2023) ‘Computing optimal drug dosing with OptiDose: implementation in NONMEM’, Journal of Pharmacokinetics and Pharmacodynamics, 50, pp. 173–188. Available at: https://doi.org/10.1007/s10928-022-09840-w.

Bräm, Dominic Stefan et al. (2023) ‘Low-dimensional neural ODEs and their application in pharmacokinetics’, Journal of Pharmacokinetics and Pharmacodynamics, null. Available at: https://doi.org/10.1007/s10928-023-09886-4.

Buettcher, Michael et al. (2023) ‘National survey in Switzerland calls for improved diagnosis and treatment in children with scabies’, Swiss Medical Weekly. 22.11.2023, 153. Available at: https://doi.org/10.57187/smw.2023.40129.

Buettcher, M and Marquez, L (2023) ‘Toxoplasmosis ESPID Education Online Course: Congenital and Perinatal Infections’, ESPID Education Online Course: Congenital and Perinatal Infections. Available at: https://education.espid.org/espid/2022/congenital-and-perinatal-infection-course/350945/faculty.presenters.module.1.introduction.html?f=menu%3D24%2Abrowseby%3D3%2Asortby%3D2%2Ace_id%3D2216%2Amarker%3D1673%2Afeatured%3D18019%2Ashow_banner_in_top_panel%3D1 .

Deichmann, Julia et al. (2023) ‘New model of glucose-insulin regulation characterizes effects of physical activity and facilitates personalized treatment evaluation in children and adults with type 1 diabetes’, PLoS Computational Biology, 19. Available at: https://doi.org/10.1371/journal.pcbi.1010289.

Golhen, Klervi et al. (2023) ‘Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children’, Pharmaceutics, 15, p. 1033. Available at: https://doi.org/10.3390/pharmaceutics15041033.

Marx, Alexander et al. (2023) ‘Blood glucose forecasting from temporal and static information in children with T1D’, Frontiers in Pediatrics, 11. Available at: https://doi.org/10.3389/fped.2023.1296904.

Steffens, Britta et al. (2023) ‘Clinically practical pharmacometrics computer model to evaluate and personalize pharmacotherapy in pediatric rare diseases: application to Graves” disease’, Frontiers in Medicine, 10. Available at: https://doi.org/10.3389/fmed.2023.1099470.

Welzel, Tatjana, Aeschlimann, Florence and Woerner, Andreas (2023) ‘Autoinflammatorische Erkrankungen’, Rheuma Schweiz, n.a.(03), pp. 62–68.

Bräm DS et al. (2022) ‘Evaluation of machine learning methods for covariate data imputation in pharmacometrics.’, CPT: pharmacometrics & systems pharmacology, 11(12), pp. 1638–1648. Available at: https://doi.org/10.1002/psp4.12874.

Nahum U et al. (2022) ‘Machine learning-based algorithm as an innovative approach for the differentiation between diabetes insipidus and primary polydipsia in clinical practice.’, European journal of endocrinology, 187(6), pp. 777–786. Available at: https://doi.org/10.1530/eje-22-0368.

Sauteur P.M.M. et al. (2022) ‘Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?’, The Lancet Microbe, 3(12), p. e897. Available at: https://doi.org/10.1016/s2666-5247(22)00190-2.

Buettcher M. and Ritz N. (2022) ‘11/m—Pain in the left leg and limping after bicycle crash: Preparation for the medical specialist examination: part 92 11/m mit Schmerzen im linken Bein und Hinken nach Fahrradsturz: Vorbereitung auf die Facharztprüfung: Fall 92’, Monatsschrift fur Kinderheilkunde, 170, pp. 491–495. Available at: https://doi.org/10.1007/s00112-022-01602-9.

Qin L et al. (2022) ‘Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations’, Journal of Human Hypertension. Epub 2021 Sep 23, 36(11), pp. 989–995. Available at: https://doi.org/10.1038/s41371-021-00600-w.

Ziesenitz VC et al. (2022) ‘Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.’, Paediatric drugs, 24(6), pp. 603–655. Available at: https://doi.org/10.1007/s40272-022-00514-1.

Weber ANR et al. (2022) ‘Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3.’, Rheumatology (Oxford, England), 61(10), pp. e299–e313. Available at: https://doi.org/10.1093/rheumatology/keac273.

Welzel T et al. (2022) ‘Tapering of biological treatment in autoinflammatory diseases: a scoping review.’, Pediatric rheumatology online journal, 20(1), p. 67. Available at: https://doi.org/10.1186/s12969-022-00725-3.

Fabienne N. Jaeger et al. (2022) ‘Prise en charge médicale des ­réfugiés mineurs d’Ukraine’, Bull Med Suisses. 03.08.2022, (103(3132)), p. 3. Available at: https://doi.org/10.4414/bms.2022.20927.

Jger, F.N. et al. (2022) ‘Junge Flchtlinge optimal versorgen’, Schweizerische Ärztezeitung [Preprint]. Available at: https://doi.org/10.4414/saez.2022.20927.

Welzel T et al. (2022) ‘Variant in the PLCG2 Gene May Cause a Phenotypic Overlap of APLAID/PLAID: Case Series and Literature Review.’, Journal of clinical medicine, 11(15). Available at: https://doi.org/10.3390/jcm11154369.

Kapp, A. et al. (2022) ‘A red herring in an unusual presentation of a rare paediatric neuroborreliosis syndrome . Supplementum 258: Abstracts of the annual meeting 2022 of the Swiss Society of Paediatrics’, Swiss Medical Weekly, 152(2122), p. w30203. Available at: https://doi.org/10.4414/smw.2022.w30203.

Zimmermann P et al. (2022) ‘Neonates with SARS-CoV-2 infection: spectrum of disease from a prospective nationwide observational cohort study’, Swiss Medical Weekly, 152(21-22). Available at: https://doi.org/10.4414/smw.2022.w30185.

Meyer Sauteur P.M. et al. (2022) ‘Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021’, Eurosurveillance, 27(19). Available at: https://doi.org/10.2807/1560-7917.es.2022.27.19.2100746.

Buettcher M (2022) ‘Borrelial lymphocytoma presentations of the ear.’, Archives of disease in childhood, 107(5), p. 490. Available at: https://doi.org/10.1136/archdischild-2021-322652.

Uka A et al. (2022) ‘Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study’, European Journal of Pediatrics, 181(3), pp. 1245–1255. Available at: https://doi.org/10.1007/s00431-021-04276-9.

Uka A et al. (2022) ‘Correction to: Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study (European Journal of Pediatrics, (2022), 181, 3, (1245-1255), 10.1007/s00431-021-04276-9)’, European Journal of Pediatrics, 181(3), p. 1257. Available at: https://doi.org/10.1007/s00431-021-04359-7.

Dao K et al. (2022) ‘Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation.’, The Journal of antimicrobial chemotherapy, 77(2), pp. 457–465. Available at: https://doi.org/10.1093/jac/dkab394.

Baumann, Philipp et al. (2022) ‘The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections’, PLoS ONE, 17. Available at: https://doi.org/10.1371/journal.pone.0264305.

Büttcher, M. et al. (2022) ‘Harnwegsinfektionen bei Kindern und Jugendlichen – Empfehlungen für Praxis und Klinik’, Padiatrische Praxis, 97, pp. 432–448.

Büttcher, M. et al. (2022) ‘Uninary tract infections in children and adolescents – recommendations for the general and hospital paediatrician/practitioner’, Internistische Praxis, 66, pp. 100–116.

Eugster NS et al. (2022) ‘Vaginale Geburt und niedriges Gestationsalter sind Hauptrisikofaktoren für Hypernatriämie bei Frühgeborenen < 32 SSW.’, Klinische Padiatrie, 234(1), pp. 20–25. Available at: https://doi.org/10.1055/a-1443-6208.

Fröhlich GM et al. (2022) ‘Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19.’, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 27(1). Available at: https://doi.org/10.2807/1560-7917.es.2022.27.1.2001848.

Golhen K et al. (2022) ‘Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis.’, Frontiers in medicine, 9, p. 944208. Available at: https://doi.org/10.3389/fmed.2022.944208.

Golhen K et al. (2022) ‘Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis.’, 10. Available at: https://doi.org/10.3389/fped.2022.909118.

Hofmann, D. et al. (2022) ‘Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or Trichuris trichiura-infected infants to adults’, J Antimicrob Chemother, 77(4), pp. 1082–1093. Available at: https://doi.org/10.1093/jac/dkac020.

Hofmann, D. et al. (2022) ‘Optimizing moxidectin dosing for Strongyloides stercoralis infections: insights from pharmacometric modeling’, Clin Transl Sci, 15(3), pp. 700–708. Available at: https://doi.org/10.1111/cts.13189.

Jaeger, F. N. et al. (2022) ‘Paediatric refugees from Ukraine: guidance for health care providers’, Swiss Med Wkly, 152(21-22), p. w30200. Available at: https://doi.org/10.4414/smw.2022.w30200.

Koch G et al. (2022) ‘Leveraging Predictive Pharmacometrics-Based Algorithms to Enhance Perinatal Care-Application to Neonatal Jaundice.’, Frontiers in pharmacology, 13, p. 842548. Available at: https://doi.org/10.3389/fphar.2022.842548.

Manduchi, Laura et al. (2022) ‘A DEEP VARIATIONAL APPROACH TO CLUSTERING SURVIVAL DATA’.

Paioni, Paolo et al. (2022) ‘Swiss recommendations on perioperative antimicrobial prophylaxis in children’, Swiss Medical Weekly, 152. Available at: https://doi.org/10.4414/smw.2022.w30230.

Pfiffner, Miriam et al. (2022) ‘Pharmacometric Analysis of Intranasal and Intravenous Nalbuphine to Optimize Pain Management in Infants’, Frontiers in Pediatrics, 10. Available at: https://doi.org/10.3389/fped.2022.837492.

Pfiffner, Miriam et al. (2022) ‘Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants’, Archives of Disease in Childhood, 108, pp. 56–61. Available at: https://doi.org/10.1136/archdischild-2022-323807.

Royston, Léna et al. (2022) ‘Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients’, Antimicrobial Agents and Chemotherapy, 66. Available at: https://doi.org/10.1128/aac.00657-22.

Samiee-Zafarghandy S et al. (2022) ‘Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates.’, Archives of disease in childhood, 107(1), pp. 86–91. Available at: https://doi.org/10.1136/archdischild-2020-321381.

Smit, C. et al. (2022) ‘Characterization of the population pharmacokinetics of moxidectin in adults infected with strongyloides stercoralis: support for a fixed-dose treatment regimen’, Clinical pharmacokinetics, 61(1), pp. 123–132. Available at: https://doi.org/10.1007/s40262-021-01048-4.

Smit, C. et al. (2022) ‘Steering away from current amoxicillin dose reductions in hospitalized patients with impaired kidney function to avoid subtherapeutic drug exposure’, Antibiotics (Basel), 11(9), p. 1190. Available at: https://doi.org/10.3390/antibiotics11091190.

Ternant D et al. (2022) ‘Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model.’, Clinical pharmacokinetics, 61(1), pp. 143–154. Available at: https://doi.org/10.1007/s40262-021-01057-3.

Welzel T et al. (2022) ‘Vaccination completeness in children with rheumatic diseases: A longitudinal, observational multicenter cohort study in Switzerland.’, Frontiers in pediatrics, 10, p. 993811. Available at: https://doi.org/10.3389/fped.2022.993811.

Welzel T et al. (2022) ‘Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial.’, Frontiers in pediatrics, 10, p. 905046. Available at: https://doi.org/10.3389/fped.2022.905046.

A Kapp et al. (2022) ‘A red herring in an unusual presentation of a rare paediatric neuroborreliosis syndrome’, in EMH SWISS MEDICAL PUBLISHERS LTD (ed.) Pädiatrie Schweiz. Luzern: Swiss Medical Weekly (Pädiatrie Schweiz), p. 1.

Büttcher M et al. (2022) ‘Harnwegsinfektionen bei Kindern und Jugendlichen – Empfehlungen für Praxis und Klinik’, Pädiatrische Praxis, (Band 97/3), pp. 432–448.

Büttcher M et al. (2022) ‘Harnwegsinfektionen bei Kindern und Jugendlichen – Empfehlungen für Praxis und Klinik’, Internistische Praxis [Preprint], (Band 066/01).

Otto M et al. (2022) ‘Semi- Mechanistic Modeling of Copeptin and Aldosterone Kinetics and Dynamics in Response to Rehydration Treatment for Diabetic Ketoacidosis in Children’, CPT: Pharmacometrics & Systems Pharmacology [Preprint], (PSP -2022-0079R1).

Heyne-Pietschmann M et al. (2021) ‘Newborns with Bloody Stools-At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship.’, Antibiotics (Basel, Switzerland), 10(12). Available at: https://doi.org/10.3390/antibiotics10121467.

Roelens, M. et al. (2021) Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR). Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2021.09.14.21263153.

Welzel T et al. (2021) ‘Colchicine - an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants.’, Pediatric rheumatology online journal, 19(1), p. 142. Available at: https://doi.org/10.1186/s12969-021-00588-0.

von Hammerstein AL et al. (2021) ‘Interseasonal RSV infections in Switzerland - rapid establishment of a clinician-led national reporting system (RSV EpiCH).’, Swiss medical weekly, 151, p. w30057. Available at: https://doi.org/10.4414/smw.2021.w30057.

Welzel T et al. (2021) ‘Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials.’, 19(1). Available at: https://doi.org/10.1186/s12969-021-00593-3.

Gotta V et al. (2021) ‘Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD-a large observational study with follow-up to young adult age.’, Pediatric nephrology (Berlin, Germany), 36(8), pp. 2421–2432. Available at: https://doi.org/10.1007/s00467-021-04972-6.

Tortorici MA et al. (2021) ‘Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy.’, CPT: pharmacometrics & systems pharmacology, 10(8), pp. 839–850. Available at: https://doi.org/10.1002/psp4.12647.

Maximiano Sousa F et al. (2021) ‘Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.’, Swiss medical weekly, 151, p. w20547. Available at: https://doi.org/10.4414/smw.2021.20547.

Deichmann, J. et al. (2021) A Comprehensive Model of Glucose-Insulin Regulation Including Acute and Prolonged Effects of Physical Activity in Type 1 Diabetes. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2021.06.09.447693.

Koch G et al. (2021) ‘The rhythm of a preterm neonate’s life: ultradian oscillations of heart rate, body temperature and sleep cycles.’, Journal of pharmacokinetics and pharmacodynamics, 48(3), pp. 401–410. Available at: https://doi.org/10.1007/s10928-020-09735-8.

Maringwa J et al. (2021) ‘Characterizing Effects of Antidiabetic Drugs on Heart Rate, Systolic and Diastolic Blood Pressure.’, Clinical pharmacology and therapeutics, 109(6), pp. 1583–1592. Available at: https://doi.org/10.1002/cpt.2130.

Zheng B et al. (2021) ‘Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients.’, British journal of clinical pharmacology, 87(6), pp. 2558–2571. Available at: https://doi.org/10.1111/bcp.14666.

Buettcher M and Imbimbo C (2021) ‘Ulceroglandular Tularemia.’, The New England journal of medicine, 384(14), p. 1349. Available at: https://doi.org/10.1056/nejmicm2031676.

Welzel T et al. (2021) ‘Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials.’, Pediatric rheumatology online journal, 19(1), p. 46. Available at: https://doi.org/10.1186/s12969-021-00514-4.

van Donge T et al. (2021) ‘Corrigendum to: Age appropriate reference intervals for eight kidney function and injury markers in infants, children and adolescents.’, 59(5). Available at: https://doi.org/10.1515/cclm-2021-0232.

Buettcher M et al. (2021) ‘Swiss consensus recommendations on urinary tract infections in children.’, European journal of pediatrics, 180(3), pp. 663–674. Available at: https://doi.org/10.1007/s00431-020-03714-4.

Buettcher M et al. (2021) ‘Correction to: Swiss consensus recommendations on urinary tract infections in children.’, 180(3). Available at: https://doi.org/10.1007/s00431-020-03820-3.

van Donge T et al. (2021) ‘Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life.’, Pediatric nephrology (Berlin, Germany), 36(3), pp. 649–659. Available at: https://doi.org/10.1007/s00467-020-04749-3.

Welzel T et al. (2021) ‘Drug-drug and drug-food interactions in an infant with early-onset SCN2A epilepsy treated with carbamazepine, phenytoin and a ketogenic diet.’, British journal of clinical pharmacology, 87(3), pp. 1568–1573. Available at: https://doi.org/10.1111/bcp.14503.

Gotta V et al. (2021) ‘Identifying key predictors of mortality in young patients on chronic haemodialysis-a machine learning approach.’, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 36(3), pp. 519–528. Available at: https://doi.org/10.1093/ndt/gfaa128.

Thiabaud A et al. (2021) ‘Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland.’, Swiss medical weekly, 151, p. w20475. Available at: https://doi.org/10.4414/smw.2021.20475.

Welzel T et al. (2021) ‘COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment.’, Journal of clinical medicine, 10(4). Available at: https://doi.org/10.3390/jcm10040605.

Lambrechtse P et al. (2021) ‘Monitoring the recovery time of children after tonsillectomy using commercial activity trackers.’, European journal of pediatrics, 180(2), pp. 527–533. Available at: https://doi.org/10.1007/s00431-020-03900-4.

Bachmann F et al. (2021) ‘OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control.’, Journal of optimization theory and applications, 189(1), pp. 46–65. Available at: https://doi.org/10.1007/s10957-021-01819-w.

Brussee, Janneke M. et al. (2021) ‘Population pharmacokinetics and exposure-response analysis of tribendimidine to improve treatment for children with hookworm infection’, Antimicrobial agents and chemotherapy, 65(2), pp. e01778–20. Available at: https://doi.org/10.1128/aac.01778-20.

Brussee, Janneke M. et al. (2021) ‘Pharmacometric analysis of tribendimidine mono- and combination therapies to achieve high cure rates in patients with hookworm infections’, Antimicrobial agents and chemotherapy, 65(2), pp. e00714–20. Available at: https://doi.org/10.1128/aac.00714-20.